From Name:
From Email:
To Name:
To Email:

Optional Message:

Lawmakers and advocates prompt CMS to reverse decision on Medicare proposal

AAGP joined advocacy groups and consumer organizations in applauding the March 10 decision by the Centers for Medicare and Medicaid Services (CMS) to reverse its plans to eliminate mental health medications from its protected classes. It was feared that the proposed CMS regulations would cause Medicare beneficiaries with a serious mental illness to have limited access to appropriate medications and impede access to affordable health plans.

CMS had issued a proposed rule on January 6, for contract year 2015, that called for the removal of antidepressants and immunosuppressant medications from the protected status they received under Medicare Part D. The proposal also called for the removal of antipsychotics from that protected status in 2016. The classes of drugs have had a protected status since the Medicare prescription drug benefit program was launched in 2006. The deadline for the comment period on the CMS proposed regulations was March 7, and CMS withdrew the proposal just one business day after that deadline. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063